Fisher & Paykel Healthcare Corp Ltd
Company Profile
Business description
Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use humidifiers, masks and related consumables and the number three player in the at-home treatment of sleep apnea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns 42% of its revenue in the US, 32% in Europe, 18% in Asia-Pacific and the remaining 8% in emerging markets. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand and Mexico and has a multichannel distribution model.
Contact
15 Maurice Paykel Place
East Tamaki
AucklandNTL2013
NZLT: +64 95740100
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
31 March 2025
Employees
7,168
Fisher & Paykel Healthcare Corp Ltd News & Analysis
stocks
A 15 step checklist from Buffett's forgotten inspiration
stocks
Are your blue-chip stocks hiding a China problem?
stocks
Are your blue chip investments hiding a China problem?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,656.40 | 89.40 | 1.04% |
| CAC 40 | 7,213.32 | 14.87 | 0.21% |
| DAX 40 | 19,146.17 | 141.39 | 0.74% |
| Dow JONES (US) | 43,870.35 | 461.88 | 1.06% |
| FTSE 100 | 8,149.27 | 64.20 | 0.79% |
| HKSE | 19,548.96 | 52.15 | -0.27% |
| NASDAQ | 18,972.42 | 6.28 | 0.03% |
| Nikkei 225 | 38,415.32 | 389.15 | 1.02% |
| NZX 50 Index | 13,031.16 | 265.92 | 2.08% |
| S&P 500 | 5,948.71 | 31.60 | 0.53% |
| S&P/ASX 200 | 8,414.80 | 91.80 | 1.10% |
| SSE Composite Index | 3,351.34 | 19.06 | -0.57% |